228 related articles for article (PubMed ID: 26890011)
1. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome.
Leerasiri P; Wongwananuruk T; Indhavivadhana S; Techatraisak K; Rattanachaiyanont M; Angsuwathana S
J Obstet Gynaecol Res; 2016 Jun; 42(6):678-83. PubMed ID: 26890011
[TBL] [Abstract][Full Text] [Related]
2. How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities.
Wang YY; Li SW; Luo S; Qin L; Zeng X; Li L; Li XH
Biomed Res Int; 2019; 2019():6126808. PubMed ID: 30854398
[TBL] [Abstract][Full Text] [Related]
3. Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age.
Guo Z; Jin F; Chen S; Hu P; Hao Y; Yu Q
BMC Endocr Disord; 2023 Apr; 23(1):89. PubMed ID: 37088815
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.
Asunción M; Calvo RM; San Millán JL; Sancho J; Avila S; Escobar-Morreale HF
J Clin Endocrinol Metab; 2000 Jul; 85(7):2434-8. PubMed ID: 10902790
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
[TBL] [Abstract][Full Text] [Related]
9. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
[TBL] [Abstract][Full Text] [Related]
10. Is acne a sign of androgen excess disorder or not?
Uysal G; Sahin Y; Unluhizarci K; Ferahbas A; Uludag SZ; Aygen E; Kelestimur F
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():21-25. PubMed ID: 28178574
[TBL] [Abstract][Full Text] [Related]
11. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
12. Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.
Zore T; Lizneva D; Brakta S; Walker W; Suturina L; Azziz R
Fertil Steril; 2019 Feb; 111(2):389-396. PubMed ID: 30527835
[TBL] [Abstract][Full Text] [Related]
13. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
Hacivelioglu S; Gungor AN; Gencer M; Uysal A; Hizli D; Koc E; Cosar E
Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
Knochenhauer ES; Key TJ; Kahsar-Miller M; Waggoner W; Boots LR; Azziz R
J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital.
Wongwananuruk T; Indhavivadhana S; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Angsuwathana S; Dangrat C
J Med Assoc Thai; 2010 Apr; 93(4):399-405. PubMed ID: 20462080
[TBL] [Abstract][Full Text] [Related]
17. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
18. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
[TBL] [Abstract][Full Text] [Related]
19. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis.
Amiri M; Ramezani Tehrani F; Nahidi F; Bidhendi Yarandi R; Behboudi-Gandevani S; Azizi F
Clin Endocrinol (Oxf); 2017 Sep; 87(3):217-230. PubMed ID: 28575537
[TBL] [Abstract][Full Text] [Related]
20. Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome.
Köşüş N; Köşüş A; Kamalak Z; Hızlı D; Turhan NÖ
Gynecol Endocrinol; 2012 Aug; 28(8):611-4. PubMed ID: 22296561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
